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Classification of Nonallergic Rhinitis Syndromes With a
Focus on Vasomotor Rhinitis, Proposed to be known
henceforth as Nonallergic Rhinopathy
Michael A. Kaliner, MD
Abstract: Many patients have nasal syndromes that are nonallergic
and noninfectious and not caused by mechanical or anatomic ab-
normalities. There are at least 8 recognized nonallergic rhinitis
syndromes: drug-induced rhinitis including rhinitis medicamentosa,
gustatory rhinitis, hormonally induced rhinitis including the rhinitis
of pregnancy, nonallergic rhinitis with eosinophilia syndrome, senile
rhinitis, atrophic rhinitis, cerebral spinal fluid leak, and vasomotor
rhinitis. Few studies have explored etiologic causes. These syn-
dromes are distinguished by clinical characteristics, recognized
triggering conditions, and concomitant observations such as nasal
eosinophilia or cerebral spinal fluid leak. Until more specific sub-
jective clinical characteristics and/or objective measures can better
define and differentiate underlying causes for these disparate dis-
eases, they will remain a murky group of overlapping syndromes.
Key Words: rhinitis, vasomotor rhinitis, allergic rhinitis,
nonallergic rhinitis, nonallergic rhinopathy
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INTRODUCTION
The generally accepted universal clinical characteristics ofthe diseases classified within the category of chronic
nonallergic rhinitis (NAR) syndromes include only the fol-
lowing: (1) nasal symptoms and (2) no evidence of concom-
itant allergic disease as determined by negative skin prick
testing for relevant allergens and/or negative allergen-specific
antibody tests. This classification automatically excludes in-
fectious rhinitis, rhinosinusitis, and mechanical/anatomical
abnormalities as causes of the chronic symptoms.
There are at least 8 separate clinical entities that can be
classified among the disorders that make up the NAR syn-
dromes (Table 1), with vasomotor rhinitis (VMR) being the
clinically most common and important one.1,2 By some esti-
mates, allergic rhinitis (AR) affects up to 58 million Ameri-
cans, whereas NAR affects more than 19 to 30 million
patients in the United States.1,3,4 In these estimates of prev-
alence, VMR is the most prevalent of the NAR syndromes.
The cost of care for allergic rhinitis in the United States is
estimated at more than $5 to 6 billion annually.5,6 It is
estimated that VMR accounts for $2 to 3 billion.1,2 Hard data
on the incidence and frequency of NAR subtypes are limited.
However, it is recognized that VMR is the most prevalent
type of NAR, affecting an estimated 37% to 61% of patients
diagnosed with rhinitis.7 In 1 survey of US medical practices,
a prospective classification of 2500 patients with rhinitis was
performed, and it was found that 43% of the patients had
“pure” AR, 23% had pure VMR, and 34% had rhinitis with
both AR and VMR features (sometimes known as mixed
rhinitis).7,8 These data suggest that at least 57% of rhinitis
patients have some contribution from NAR causing their
rhinitis symptoms. Similar European studies have found that
approximately 1 in 4 patients complaining of nasal symptoms
has “pure” NAR.9 Recent estimates suggest that 50 million
Europeans have NAR, with a total prevalence of more than
200 million worldwide.10
CLASSIFICATION OF NAR SYNDROMES
There have been several recent attempts at classifying
the chronic nasal syndromes not associated with allergic
disease.2,11,12 The reader is referred to these references for
additional approaches to this problem and for a more com-
plete bibliography.12 The approach taken herein combines the
overall recommendations from these 3 sources, combined
with input from other experts at a consensus conference from
which this series of papers is derived.
There are at least 8 subtypes that fill the criteria for
nonallergic rhinitis (Table 1): drug-induced rhinitis, gustatory
rhinitis (rhinorrhea associated with eating, especially hot and
spicy foods), hormonally induced rhinitis, nonallergic rhinitis
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with eosinophilia syndrome (NARES), senile rhinitis, atrophic
rhinitis, cerebral spinal fluid (CSF) leak, and vasomotor rhinitis
(VMR).2 The 2 nonallergic processes, infectious rhinitis (includ-
ing bacterial rhinitis and chronic rhinosinusitis) and mechanical/
anatomical abnormalities, are excluded from this classification.
Hormonally induced rhinitis reflects responses to en-
dogenous female hormones. The rhinitis of pregnancy is an
extremely common condition, affecting up to 20% to 30% of
pregnancies, and particularly notable during the last trimes-
ter.13 It typically resolves spontaneously within 2 weeks of
delivery. As 1 clue to specific causes, Ellegard showed that
women with rhinitis of pregnancy had elevated serum pla-
cental growth hormone levels compared to pregnant women
without rhinitis.14 However, it is usually assumed that the
rhinitis of pregnancy reflects the mucosal engorgement found
in the last trimester as a consequence of progesterone stimula-
tion. Thus, the nasal mucosa becomes engorged and congestion
ensues, as all of the mucous membranes are affected by the
hormonal changes of pregnancy.15 Some patients develop sim-
ilar symptoms premenstrually on a cyclical basis.15
Drug-induced rhinitis includes rhinitis medicamentosa,
which is the descriptive name for the nasal congestion and
rebound rhinitis caused by repeated administration of topical
nasal decongestants. The most common cause of rhinitis medi-
camentosa is overuse of topical nasal decongestants such as
oxymetazoline or phenylephrine. When used briefly (less than
3–5 days consecutively), these medications provide significant
relief of nasal congestion. However, with chronic use, rebound
nasal congestion can occur and can be quite severe. The exact
mechanism is poorly understood but theories suggest involve-
ment of recurrent nasal tissue hypoxia and negative neural
feedback with chronic decreased -2 receptor responsiveness.16
More broadly, other medications12 can cause chronic
nasal symptoms through a host of different mechanisms.
Antihypertensive medications including -blockers, angio-
tensin converting enzyme inhibitors, reserpine, calcium chan-
nel blockers, and methyldopa cause nasal congestion. A very
bothersome side effect seen with -receptor antagonists used
for benign prostatic hyperplasia and phospophodiesterase-5
inhibitors for erectile dysfunction is nasal congestion. Aspirin
and nonsteroidal anti-inflammatory drugs also may contribute
to congestion, especially in patients with a history of nasal
polyposis. Oral contraceptive pills also can cause congestion
in some women. Personal observations by members of the
roundtable (Roundtable Meeting, December 13, 2008, Wash-
ington, DC) suggest that topical eye drops such as -blockers
for glaucoma may also cause nasal symptoms.
Chronic nasal symptoms are associated with a variety of
medical conditions, the full range of which is beyond the scope
of this article (Table 2). For example, nasal congestion can be
seen in distinct diseases such as hypothyroidism and chronic
fatigue syndrome. Baraniuk and colleagues found that 46% of
patients with chronic fatigue syndrome also have NAR and that
76% of these patients have ongoing nasal complaints.17 Gastro-
esophageal reflux disease or laryngeal-pharyngeal reflux can
both lead to chronic postnasal drip and other throat symptoms,
and in severe cases, they can also cause nasal congestion.18
Anatomical anomalies can also contribute to NAR. Adenoid
hypertrophy, nasal septal deviation, and idiopathic turbinate
hypertrophy or other structural abnormalities can cause chronic
nasal obstruction with little relief from medications. Surgical
intervention can be curative.
Senile rhinitis is a clinically defined condition most com-
mon in the elderly and can lead to persistent watery rhinorrhea
that may be worsened by food or environmental irritants. Gus-
tatory rhinitis is the condition that causes anterior rhinorrhea
and/or postnasal drip after eating, especially hot or spicy foods.19
Gustatory rhinitis is more frequent in older individuals and
overlaps with senile rhinitis. Both gustatory and senile rhinitis
involve excessive secretions and are effectively treated with
topical anticholinergic agents.19 They can occur concomitantly
and are often found in patients with classic VMR.
Atrophic rhinitis may occur as a primary, idiopathic
syndrome with mucous gland atrophy or as a secondary
syndrome after overzealous surgeries, with too many mucus-
secreting tissues removed. Because mucus is required to
TABLE 1. Chronic Rhinitis Syndromes that are Nonallergic
and Noninfectious and Not Due to Anatomical/Mechanical
Causes*
● Drug-induced rhinitis, including rhinitis medicamentosa
● Gustatory rhinitis
● Hormonal-induced rhinitis, including the rhinitis of pregnancy
● Nonallergic rhinitis with eosinophilia
● Senile rhinitis
● Atrophic rhinitis
● Cerebral spinal fluid leak
● Nonallergic rhinopathy (NAR), previously known as vasomotor rhinitis
(VMR), or idiopathic nonallergic rhinitis
*Both anatomic/mechanical abnormalities and chronic infectious rhinitis and rhi-
nosinusitis are excluded.
Adapted from J World Allergy Org. 2009;2:20–25 and J Allergy Clin Immunol.
2008;122(2 suppl):S1–S84.

















● Chronic fatigue syndrome
● Gastro-esophageal reflux and laryngopharyngeal reflux
Adapted from Clin Allergy Immunol. 2007;19:23–34 and J Allergy Clin Immunol.
2008;122(2 suppl):S1–S84.
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restrict bacterial growth in mucous membranes, these patients
have dry mucosa and often contract ozena. A few bacterial
diseases (pseudomonas ozena and Klebsiella rhinoscleroma-
tis) also can cause atrophic rhinitis.12
CSF leak in patients with a history of cranio-facial
trauma or past facial/sinus surgeries must be considered when
evaluating persistent rhinorrhea. Increased intracranial pres-
sure can increase the risk of spontaneous CSF leak.
Historically, NAR variants have been divided into 2
groups based on nasal cytology: NARES and non-NARES.
However, in this era, nasal cytology is rarely performed in
clinical practice. When NARES was described,20 patients had
the same spectrum of symptoms as seen in AR and were
noted to have eosinophilia in nasal secretions. However, skin
testing and radioallergosorbent testing were negative. Thus,
these eosinophilic patients all had the hallmarks of AR except
for specific IgE antibodies. NARES patients characteristically
respond well to topical nasal corticosteroids. Unfortunately,
most clinicians no longer do nasal smears, and we do not
know the relationship of NARES to the other forms of NAR.
“Occupational rhinitis” is not a separate category but
simply designates the location where exposure to nasal trig-
gers is encountered. In practice, many patients complain of
occupational rhinitis. Rhinitis from occupation exposures can
be caused by irritants and/or allergens. Noxious fumes, odors,
and environmental irritants are classic provocateurs of occu-
pational rhinitis, whereas colophony (solder fumes), chemi-
cals, enzymes, and countless other manufacturing by-prod-
ucts can act as allergens to some exposed people.12,21 With
cleaner, more controlled environments, one might expect
fewer occupational diseases in today’s world, but patients
often believe that work-related exposures are still a common
cause of rhinitis. A good history, combined with inventive
provocations (such as exposure to soldering fumes or deter-
gent powder), helps define what condition or exposure is
responsible for the patient’s problems.21
Chronic rhinosinusitis, with or without nasal polyps, is
another cause of chronic rhinitis.22,23 The symptoms of nasal
congestion, postnasal drip with throat clearing and cough,
facial pressure, headache, purulent drainage, and anosmia
should lead the astute clinician to examine suspected sinus
involvement. Because the inflammation in sinusitis may be
infectious or immunologically mediated, these syndromes
are usually not considered part of the nonallergic rhinitis
syndromes.12,22–24
Aspirin-exacerbated respiratory disease usually in-
cludes NAR as 1 of the clinical characteristics, along with
sinusitis, nasal polyposis, asthma, and eosinophilia worsened
with aspirin or nonsteroidal anti-inflammatory drug expo-
sure.12 The NAR seen in aspirin sensitivity is usually a form
of NARES and may precede the development of the other
manifestations of the syndrome.
NONALLERGIC VASOMOTOR RHINITIS, WHICH
IS NOW PROPOSED TO BE CALLED
NONALLERGIC RHINOPATHY
The most frequent form of NAR observed clinically is
vasomotor rhinitis (VMR) or idiopathic rhinitis, characterized
by persistent or intermittent nasal symptoms that can be
triggered by environmental conditions that do not bother
normal individuals. These triggers include the following:
strong odors; exposure to cold air; changes in temperature,
humidity, and/or barometric pressure; ingestion of alcoholic
beverages; and changes in menstrual-related hormone levels.
Patients can also have persistent symptoms in the absence of
identified triggers. The diagnosis of VMR is primarily made
by clinical history and exclusion of other known causes. If a
patient has appropriate nasal symptoms (usually rhinorrhea,
congestion, postnasal drip, headaches, facial pressure, throat
clearing, and/or coughing) worsened or triggered by 1 or
more of the environmental conditions noted above, then
VMR is present. Concomitant ocular symptoms tend to be
minimal, and the symptoms of nasal and palatal itch and also
sneezing spells are not common.
Some patients with nonallergic rhinopathy have persis-
tent nasal symptoms and no other recognized cause. These
patients may or may not respond to the environmental con-
ditions that trigger other symptoms in other patients. The
clinical characteristics of these patients (predominantly fe-
male, adult onset, clinical symptoms, and response to treat-
ment) are indistinguishable from VMR patients with recog-
nized triggers. It is proposed that these patients also have
VMR.
Unlike AR, VMR is usually adult onset and is not
worsened by exposure to classic allergens such as pollen,
house dust mite, dogs, or cats. A validated questionnaire has
been created to help identify NAR patients.25 Because VMR
may be caused by shifts in temperature, humidity, and/or
barometric pressure, patients may experience seasonal symp-
toms associated with changes in these climatic conditions
experienced during the spring and fall. Seasonal VMR can,
therefore, be confused with seasonal allergic rhinitis.26
The diagnosis of VMR is based solely upon the pa-
tient’s history of symptoms and their triggers, whereas the
diagnosis of AR requires an appropriate history and confir-
matory allergy testing—either positive relevant skin prick
tests or radioallergosorbent tests. These 2 diseases are not
mutually exclusive, and at least 60% of AR patients develop
nasal symptoms in response to nonallergic environmental
triggers. To have “pure” nonallergic rhinopathy, however, the
patient must have negative relevant skin tests or in vitro
allergen-specific antibody tests.
There are some limited data that histamine can be
released by inhaling cold, dry air, which elicits cold-air-
induced rhinitis in some sensitive patients. In a set of cold,
dry air challenges, in vivo histamine release was observed
with cold-air-induced rhinitis patients but not with other
forms of NAR.27 The importance of the histamine release to
the development of the rhinitis symptoms was considered to
be unrelated.
The epidemiologic predominance of females with
VMR suggests that female hormones might play some role,
but there is little supporting data. One study reported that
71% of patients with VMR were women compared with
62% of those with mixed rhinitis and 55% of those with
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AR.25 These data are consistent with findings from other
studies.1,2,15
CONCLUSIONS
Nonallergic rhinitis syndromes are heterogeneous and
are often unrelated to each other. The 1 thing that these
diseases have in common is that they are chronic, bothersome
nasal conditions that do not involve allergic mechanisms.
Few studies have explored etiologic causes, although it is
recognized that sensory neuropeptides and cholinergic ef-
fecter discharges are involved in gustatory and senile rhinitis.
There are data that neurosensory abnormalities play a role in
nonallergic rhinopathy as well. However, until more specific
subjective clinical characteristics and/or objective measures
can better define and differentiate underlying causes for these
disparate diseases, they will remain a murky group of over-
lapping syndromes.
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